Litcius/Paper detail

First-in-Asian double-blind randomized trial to assess the efficacy and safety of insulin sensitizer in nonalcoholic steatohepatitis patients

Jee‐Fu Huang, Chia‐Yen Dai, Chung‐Feng Huang, Pei‐Chien Tsai, Ming‐Lun Yeh, Po‐Yao Hsu, Shiu-Feng Huang, Ming‐Jong Bair, Nai‐Jen Hou, Ching‐I Huang, Po‐Cheng Liang, Yi‐Hung Lin, Chih‐Wen Wang, Ming‐Yen Hsieh, Shinn‐Chern Chen, Zu-Yau Lin, Ming‐Lung Yu, Wan‐Long Chuang

2021Hepatology International63 citationsDOI

Topics & Concepts

PioglitazoneMedicineInternal medicineSteatohepatitisHepatologyPlaceboGastroenterologyClinical endpointRandomized controlled trialAdverse effectNonalcoholic steatohepatitisFibrosisLiver biopsyFatty liverDiabetes mellitusType 2 diabetesSurgeryBiopsyNonalcoholic fatty liver diseaseEndocrinologyPathologyAlternative medicineDiseaseLiver Disease Diagnosis and TreatmentDiabetes, Cardiovascular Risks, and LipoproteinsDiet and metabolism studies